LONGUEUIL, QC, June 26, 2014 /CNW Telbec/ – Héroux-Devtek Inc. (TSX: HRX) (“Héroux-Devtek” or the “Corporation”), a leading Canadian manufacturer of aerospace products, announced today that is has completed its previously-announced equity financing comprised of a “bought deal” short form prospectus offering of 3,158,000 common shares of the Corporation at a price of $11.75 per share for gross proceeds to the Corporation of $37,106,500 (the “Public Offering”) and concurrent private placements of an aggregate of 1,097,871 common shares of the Corporation at a price of $11.75 per share for gross proceeds to the Corporation of $12,899,984 (the “Concurrent Private Placements”).
The syndicate of underwriters for the Public Offering was co-led by National Bank Financial Inc. and TD Securities Inc., acting as co-lead underwriters and joint bookrunners, and included Scotia Capital Inc., Desjardins Securities Inc., Laurentian Bank Securities Inc. and Raymond James Ltd. The investors in the Concurrent Private Placements were the Caisse de dépôt et placement du Québec and the Solidarity Fund QFL.
The Corporation intends to use the net proceeds from the Public Offering and the Concurrent Private Placements to repay indebtedness under its credit facility.
No securities regulatory authority has either approved or disapproved the contents of this press release. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Corporation in any jurisdiction in which such offer, solicitation or sale would be unlawful. These securities have not been and will not be registered under the United States Securities Act of 1933, as amended or any U.S. state securities law and may not be offered or sold in the United States except in compliance with the registration requirements of said Act and applicable U.S. state securities laws or pursuant to an exemption therefrom.